ADRB2 and neoplasm: In contrast, antagonism of β-ARs through propranolol or β2-AR deletion reduced the accumulation of MDSCs in spleens and tumor tissue of tumor-bearing mice while increasing T cell infiltration and suppressing tumor growth (74).